Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now?

Omeros Corporation (NASDAQ:OMER) is among the best get rich quick stocks to buy right now. On June 26, Brandon Folkes from H.C. Wainwright trimmed the price target on Omeros Corporation (NASDAQ:OMER) to $33 from $40 and reaffirmed a Buy rating. This price revision follows a “disappointing” negative CHMP opinion for Yartemlea. While the news is likely to weigh on the stock in the near term, the analyst believes it isn’t entirely “thesis-breaking.”

Folkes views the U.S. Yartemlea launch as a key value driver for Omeros Corporation (NASDAQ:OMER). The price cut is based on the firm’s removal of the EU opportunity from its model and the higher R&D spending guidance.

What’s truly impressive is the company’s one-year return. Omeros Corporation (NASDAQ:OMER) delivered a solid return of 200.32% in contrast to the S&P 500’s return of 20.17%. While the company’s year-to-date performance is negative, its upside potential is approximately 374%. With that, OMER is among the best get rich quick stocks to buy right now.

Omeros Corporation (NASDAQ:OMER), incorporated in 1994, is a Washington-based clinical-stage biopharmaceutical company specializing in small-molecule and protein therapeutics.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.